Digitally-Augmented Drugs: A Practical Experience for Growing Pharma Portfolios

One-Pager

Introduction

Drug development is increasingly complex and expensive for pharmaceutical companies. “Digitally-augmenting drugs” is one of the strategies to secure the value of drug assets. As the field is moving fast, we hosted an online discussion with seasoned industry executives who pioneered the space of digital/drug combinations during the past decade. They shared key learnings from their practical experience that we summarized in this one-pager. Feel-free to share your thoughts and join the conversation by contacting our team.

…